Mon, 21 Mar 2011: 

Stock-PR Reporting

stockpr_logo-site

FREE Daily Stock Alerts From Stock-PR.com

chartstockalert

________________________________________

Power3 Medical Products, Inc. (PWRM.OB)

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.

In addition, Power3 is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by Power3 several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash. Because current management believes these toxic debt instruments are responsible for Power3’s depressed stock price and have distracted the company from its mission, Power3 plans to settle as many of these nagging lawsuits as possible prior to the completion of its merger with Rozetta-Cell Life Sciences, Inc. As for those lawsuits that cannot be speedily resolved, Power3 will continue to rigorously defend its position. For example, one such lawsuit involves Neogenomics, Inc., which was recently granted a motion for summary judgment with respect to an amount due under a convertible debenture. Power3 intends to appeal this decision.

“We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now,” stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc. “We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for Power3 is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger.”

Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in 2011.

http://pennyomega.com/img/nhpr.jpg National Health Partners, Inc. (OTCBB:NHPR)

National Health Partners, Inc., a leading provider of unique discount healthcare membership programs, recently announced that NHPR has achieved positive earnings for the quarter ended September 30, 2010 compared to a loss of $522,542 for the same period last year. Revenues for the 3rd quarter grew 12.3% over the same period last year. NHPR attributes the net earnings to the significant cost-cutting initiatives taken over the past couple of quarters and which is continuing in the 4th quarter.

A substantial bulk of research shows that there are serious health and financial consequences associated with not having insurance. Also, research shows that leaving a large share of the population without health insurance affects not only those who are uninsured, but also the health and economic wellbeing of the country. Yet, despite these findings, the number of uninsured Americans continues to sky-rocket. Although the national debate over ensuring health coverage for more Americans at times gains momentum, it then stalls—maybe in part because not enough is known about both the benefits and the costs of expanding coverage to more, if not all, of the uninsured.

National Health Partners, Inc. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called “CARExpress.” CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna. NHPR’s primary target customer group is the 47 million Americans who have no health insurance of any kind. NHPR’s secondary target customer group includes the millions of Americans who lack complete health insurance coverage. NHPR is headquartered in Horsham, Pennsylvania.

To learn more about NHPR visit: http://www.nationalhealthpartners.com

Perma-Fix Environmental Services Inc. (Nasdaq:PESI) announced results for the fourth quarter and full year ended December 31, 2010.Revenue for the fourth quarter of 2010 was $25.5 million versus $26.4 million for the same period last year. Overall revenue for the Nuclear Segment increased to $95.3 million from $89.0 million for the same period in 2009. Revenue generated from the DOE Hanford Site increased approximately $697,000 or 7.1% for the quarter. Revenue from the Engineering Segment decreased to $537,000 from $711,000 for the same period in 2009 primarily due to decrease in billable hours as their engineering business continues to be impacted by economic uncertainty.Gross profit for the fourth quarter of 2010 was $5.9 million versus $8.3 million for the fourth quarter of 2009 primarily due to lower revenue and revenue mix. Higher on-site services revenue, which generally carries lower margins, replaced treatment revenue at the facilities.
Perma-Fix Environmental Services, Inc., through its subsidiaries, operates as an environmental and technology know-how company in the United States.

Paulson Capital Corp. (Nasdaq:PLCC) reported a net loss for the year ended December 31, 2010 of $1,215,815 (or ($0.21) per share) versus a net loss for the same period 2009 of $2,425,122 (or $0.41 per share). Revenues for the twelve months totaled $18,094,472 versus $15,244,943 for the like period in 2009.
Paulson Capital Corp., through its subsidiary, Paulson Investment Company, Inc., operates as a brokerage company principally in the United States.

Supertel Hospitality, Inc. (Nasdaq:SPPR) announced its results for the fourth quarter and year ended December 31, 2010. Revenues from continuing operations for the 2010 fourth quarter increased 6.5 percent to $19.2 million, compared to the year-ago period, and increased 3.1 percent to $84.1 million for the full year. Net loss attributable to common shareholders was $(4.2) million, or $(0.18) per diluted share, for the 2010 fourth quarter, compared to net loss attributable to common shareholders of $(25.7) million, or $(1.17) per diluted share, in the 2009 same quarter. For the full year 2010, net loss attributable to common shareholders was $(12.1) million, compared with net loss attributable to common shareholders of $(28.9) million in 2009.
Supertel Hospitality, Inc., a real estate investment trust (REIT), engages in the ownership and acquisition of limited-service hotels in the United States.

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 3,000,000 shares of (144) restricted common stock from the company and 3,000,000 shares of free trading shares from a third party (PIERRE BESUCHET) for six months of advertisement services for National Health Partners Inc. (NHPR.OB).

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

http://stock-pr.com/img/stock-pr_buscard.jpg

________________________________________

Be Sure To Visit stock-pr.ning.com

**********************************************************************

The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.

 
Share/Bookmark